Search Results
Results found for "Martine Smit"
- Dr. Nicola J. Smith - Dr. GPCR Podcast
Nicola Smith, Molecular Pharmacologist, lab head, and senior lecturer at UNSW Sydney.
- Genome-wide identification of 216 G protein-coupled receptor (GPCR) genes from the marine water ...
Genome-wide identification of 216 G protein-coupled receptor (GPCR) genes from the marine water flea Here, we identified a total 216 full-length GPCR genes in the marine water flea Diaphanosoma celebensis
- Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids
We have carried out MARTINI coarse-grained molecular dynamics simulations of SMO in POPC and in ciliary
- Ode to GPCRs
The 1994 Nobel Prize in Physiology or Medicine was awarded to Alfred Goodman Gilman and Martin Rodbell Martin Rodbell – Facts - NobelPrize.org. https://www.nobelprize.org/prizes/medicine/1994/rodbell/facts Martin Rodbell – Nobel Lecture - NobelPrize.org. https://www.nobelprize.org/prizes/medicine/1994/rodbell
- Chemokine receptor-targeted drug discovery: progress and challenges
the engagement of the receptor with a certain effector, thus enriching a specific signaling pathway (Smith In fact, the requirements in terms of safety margin, oral bioavailability, and frequency of administration
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
For drug discovery teams navigating safety margins, biased signaling, and combination therapy design, Recognizing how your ligand interacts with the receptor lets you predict safety margins, dose–response
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
contributes to inflammatory joint pain Luke A Pattison , Rebecca H Rickman , Graham Ladds , Ewan St John Smith
- 📰 GPCR Weekly News, May 20 to 26, 2024
Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery Nicola J Smith
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Nichola J Smith's investigation: Gene expression of TAS1R taste receptors for cardiometabolic disease
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
.; Martin, B. R.; Abood, M. E. J Pharmacol Exp Ther 1996 , 278 (3), 989–999. (12) Martín-Fontecha, M.; Angelina, A.; Rückert , B.; Rueda-Zubiaurre, A.; Martín-Cruz, L.; Van De Veen, W.; Akdis, M.; Ortega-Gutiérrez, S.; López-Rodríguez
- 📰 GPCR Weekly News, March 25 to March 31, 2024
This week's highlight includes congrats to: Junyi Liang, Niña Caculitan, and Adam W Smith for their research
- Differential binding of Δ9-tetrahydrocannabinol derivatives to type 1 cannabinoid receptors (CB1)
acceptor is sufficient for a transmission of energy to occur between the Tb and fluorophore, which will emit
- Radioligands vs. Fluorescent Ligands: Binding Assays
One of the atoms in the original molecule is replaced by a radionuclide, which emits radiation.
- Unlocking the Future of Medicine: Advancements in GPCR Research
Elucidation, and Biological Activity of the Selective TACR2 Antagonist Tumonolide and its Aldehyde from a Marine disordered C-terminal domains Industry News Novartis continues to deliver strong sales growth and core margin
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
By measuring the way these cells scatter light and emit fluorescence, they can be identified, quantified
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
previously established chemical space, limiting their ability to identify truly novel chemotypes”(Thomas, Smith
- Advantages of Fluorescent Probes in GPCR Assays
This can be fixed by using fluorescent dyes that emit at longer wavelengths, where fluorescence from









